OPEN LABEL

Clinical trials for OPEN LABEL explained in plain language.

Never miss a new study

Get alerted when new OPEN LABEL trials appear

Sign up with your email to follow new studies for OPEN LABEL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New cancer drug combo enters first human tests

Disease control Recruiting now

This early-stage trial tests a new oral drug, FX-909, alone or with pembrolizumab, in people with advanced solid tumors like bladder cancer. The main goals are to check safety and find the right dose. About 120 adults will take the drug daily and have regular scans and blood test…

Matched conditions: OPEN LABEL

Phase: PHASE1 • Sponsor: Flare Therapeutics Inc. • Aim: Disease control

Last updated May 17, 2026 05:26 UTC

OPEN LABEL

Get alerted when new OPEN LABEL trials appear

New cancer drug combo enters first human tests